Transferrin protein and iron uptake by isolated rat erythroblasts  by Octave, Jean-Noël et al.
Volume 137, number 1 FEBS LETTERS January 1982 
TRANSFERRIN PROTEIN AND IRON UPTAKE BY ISOLATED RAT ERYTHROBLASTS 
Jean-Noel OCTAVE, Yves-Jacques SCHNEIDER, Robert R. CRICHTON and Andre TROUET 
Universitt Gztholique de Louvain (Laboratoire de Chimie Physiologique et Unit6 de Biochimie) UCL-ICP 75.39, 
Avenue Hippocrate 7.5, 1200 Bruxelles and International Institute of Cellular and Molecular Pathology, 
Louvain-la-Neuve and Bruxelles, Belgium 
Received 23 November 1981 
1. Introduction 
In mammals, the major proportion of body iron is 
found as the iron porphyrin complexes, haemoglobin, 
myoglobin and a variety of haem-containing enzymes. 
Many other iron proteins are found in the tissues, 
including metallo-flavoproteins and other enzymes in 
which iron is a cofactor. Iron is also stored within the 
body as ferritin and haemosiderin which are specially 
designed for retaining iron in a soluble and bioavailable 
form. Mammals have the unique ability to conserve 
body iron but a markedly limited capacity to absorb 
and excrete it (review [ 11). This conservative charac- 
ter of iron metabolism implies multiple and rapid 
exchanges of the metal between different body com- 
partments. Within the body, iron exchanges between 
tissues are effected by a carrier protein in the plasma, 
transferrin, which interacts with tissue receptors. The 
problem still to be elucidated is to know how, after 
binding of transferrin to its receptor, iron moves into 
the cell and between functional compounds and stor- 
age depots. Considering the ways in which transferrin 
iron could be assimilated by cells, a number of possi- 
bilities can be envisaged. Perhaps the most evident is 
that once bound to its plasma membrane receptor, 
the transferrin molecule would release its iron at the 
plasma membrane and thereafter be returned to the 
extracellular medium while the iron would be trans- 
ported to the intracellular sites where it is required. A 
second possibility is that the iron-loaded transferrin 
molecule is internalised within the cell prior to iron 
release. This would be compatible with morphological 
evidence based on studies in reticulocytes and ery- 
throid cells with 1251-labelled transferrin and with 
transferrin conjugated to ferritin or to peroxidase 
AC blished by ElsevierlNorth-Holland Biomedical Press 
[2,3]. On the basis ofkinetic studies of the interaction 
of 59Fe-saturated, ‘H-labelled transferrin with cul- 
tured rat fibroblasts, we have proposed [4] that these 
cells take up iron by receptor-mediated endocytosis 
of transferrin, release of iron inside the lysosomes as a 
result of the acidic pH prevailing in these granules [5] 
and recycling of iron-depleted transferrin to the cell 
surface. We have also reported [6,7] that lysosomo- 
tropic substances, in particular chloroquine and meth- 
ylamine, strongly decrease the transferrin iron uptake 
by fibroblasts. Since these drugs increase the intralyso- 
somal pH of macrophages from 4.8-6.2 [5], a pH at 
which the affinity of iron for transferrin is much 
higher than at pH 4.8, affect endocytosis and in par- 
ticular membrane and receptor recycling [8-lo]. We 
concluded that these data could provide us with strong 
arguments in favour of our working hypothesis. 
An important problem is also to determine whether 
this mechanism is restricted to cultured fibroblasts, or 
whether it could be extended to other cell types. 
Recently, comparable results have been obtained with 
totipotent mouse teratocarcinoma cells and a similar 
model has been proposed [ 111. 
We have therefore investigated the uptake of iron 
from s9Fe-saturated, 3H-labelled transferrin by rat 
erythroblasts. These red cell precursors synthesize 
very large amounts of haemoglobin and therefore 
have a requirement of iron which is many times 
greater than that of other cells. We report here on 
experiments which show that isolated rat erythroblasts 
display specific receptors for transferrin, at their cell 
surface, accumulate transferrin iron and that chloro- 
quine and methylamine greatly reduce iron uptake’ 
from transferrin. 
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2. Materials and methods 
Rat serum transferrin was isolated as in [4] by 
chromatography on DEAE-cellulose, filtration through 
Ultragel 4.4 and a final chromatography on wheat 
germ lectin. The transferrin was labelled with 3H by 
reductive methylation [ 121 using sodium [3H] boro- 
hydride (5-20 Ci/mmol, Radiochemical Centre, 
Amersham). Apotransferrin was prepared by dialysis 
against 0.05 M sodium acetate buffer @H 5.5) con- 
taming 0.05 M EDTA. The apotransferrin was labelled 
with s9Fe as ferric citrate (25 mCi/mmol, IRE) to 
have a specific activity close to that of 3H (-10 000 
dpm/l.cg protein in both isotopes). The transferrin was 
subsequently saturated with non-radioactive iron to 
give an A46s/A280 ratio of 0.046 [ 13 1. Erythroblasts 
were prepared according to [14]. In brief, after isola- 
tion from 16 day rat embryos (Wistar strain), the livers 
were homogenized in the Iscove culture medium 
(Gibco-Biocult, Paisley) by 5 passages through a 19 G 
needle. The cells obtained in these conditions were 
>90% erythroid cells [ 141. After incubation in the 
presence of trypan blue, the cells were counted using 
a Biirker cell; on the other hand, cellular proteins 
were determined by the Lowry method and it was 
established that 1 mg protein corresponds to -6 X lo6 
cells. 2 X lo6 cells (-0.6 mg protein) were incubated 
at 0 or 37’C in 9 cm* plastic Petri dishes or in sterile 
plastic tubes (Becton Dickinson, Villeneuve-la- 
Garenne) containing 1 ml Iscove culture medium in 
which the labelled transferrin had been diluted. At 
the end of the incubation, the cells were separated 
from the culture medium by centrifugation through 
600 fl dibutylphthalate in propylene microtubes in a 
Beckmann microfuge for 30 s as in [ 15 1. After 
removal of the supernatant, the cells were solubilised 
with 1% (w/v) sodium deoxycholate adjusted to 
pH 11.3 with NaOH. The radioactivity accumulated 
by the cells was measured using an aqualuma cocktail 
(Lumac Systems, Basle) in a Tri-Carb 460 CD scintil- 
lation counter (Packard Instruments, San Diego CA); 
all samples were corrected for quenching. Cell protein 
was determined by the Lowry method [ 161 using 
bovine serum albumin as a standard. The results are 
expressed as dpm/mg cell protein. The drugs were 
employed at a final concentration at which no toxic 
effect was detected by observation under phase con- 
trast microscopy throughout the incubation time. 
For some experiments, the collected media were 
assayed for degradation products after precipitation 
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of proteins by 15% (w/v) tricbloroacetic acid followed 
by 30 min centrifugation at 1500 X g; the trichloro- 
acetic acid supematants were assayed for radioactivity 
as above. The nature of the cell-associated iron was 
analysed by isokinetic centrifugation of cell lysates 
on preformed linear sucrose density gradient 
(1.017-1.152 g/cm3). After 64 h centrifugation at 
4°C and 36 000 rev./min (Rotor SW41 in L550 
Beckmann centrifuge), the gradient was eluted in 
30 fractions and the distribution profile of the cell- 
associated 59Fe was compared to those of labelled 
[3H] transferrin or [“Fe] haemoglobin used as stan- 
dards .
3. Results 
3.1. Low temperature binding of transfer& 
At 0°C in the presence of 10 @g/ml 59Fe-loaded, 
3H-labelled transferrin, both isotopes attach to rat 
erythroblasts in comparable amounts and a plateau is 
reached after -20 min (fig.lA). As a function of the 
[3H] transferrin concentration, increasing amounts of 
3H label are bound to the cells but no plateau is 
attained (fig.1 B). Assuming M, 80 000 for transferrin 
and 6 X 10” erythroblasts/mg cell protein, the 
Scatchard analysis of the binding parameters (fig.lC) 
indicates the presence of -500 000 high affinity 
(K, 2.5 X 10’ M-l) sites/cell. 
3.2. Up take of 59 Fe-loaded ( “H] h-ansfemh 
As indicated by tig.2, after 15 mm incubation at 
37’C, the cells accumulate both “Fe and 3H, in a 
process saturable with the transferrin concentration 
(half saturation reached at -0,125 PM, i.e., l/300 of 
the physiological concentration); the uptake of “Fe 
is however higher than that of 3H. As a function of 
the incubation time (fig.3), the uptake of “Fe pro- 
ceeds proportionally with time up to 6 h and then 
more slowly. After 20 h, it corresponds to the uptake 
of the iron bound to 55 /..tg transferrinimg cell protein, 
i.e., -20% of the amount initially present in the cul- 
ture medium indicating that most probably the slow 
down in the uptake of s9Fe results from a partial 
exhaustion of the medium in transferrin iron. To 
study the nature of the cell associated iron, homoge- 
nates of erythroblasts incubated for different times at 
37°C in the presence of labelled [“Fe] transferrin 
were analysed by isokinetic centrifugation on sucrose 
gradients. After 30 min incubation, half of the cell- 
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Fig.1. Erythroblasts (-300 pg protein) were incubated at 0°C for different times (A) or for I h (B) in I ml medium containing 
10 pg/ml (A) or different concentrations (B) of 59Fe-loaded (A) 3H-labelled transferrin (A,B) (spec. act. -10 000 dpm/rg in both 
isotopes). (C) Scatchard analysis of the data of (B): the abscissa represents the transferrin bound/mg cell protein; the ordinate is 
the ratio of bound to free transferrin: (0) 59Fe; (0) ‘H. Mean of 3 independent experiments + SD (A,B). 
bound radioactive iron is associated with low M, 
products, half with molecules behaving like ferritin. 
After 24 h incubation, the proportion of iron asso- 
ciated with ferritin does not change but -30% of iron 
accompanies haemoglobin. The accumulation of 3H- 
label by erythroblasts very rapidly reaches a plateau 
and after 6 h incubation the amount of cell-associated 
3H-label is lo-times lower than that of 59Fe. In paral- 
lel to the accumulation of labelled material by the 
cells, no degradation products soluble in trichloro- 
acetic acid are detected in the culture medium, even 
after 20 h indicating that transferrin is not digested 
by the cells. 
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Fig.2. Cells (-300 ng protein) were incubated for 15 min at 
37°C in 1 ml culture medium containing different concentra- 
tions of 59Fe-loaded, ‘H-labelled transferrin (spec. act. as in 
fig.1). Mean results ? SD of 3 independent experiments are 
given: (0) *‘Fe uptake by the cells; (0) [ )H] transferrin uptake 
by the cells. 
Fig.3. Cells (-300 fig protein) were incubated in 9 cm* Petri 
dishes for different durations at 37°C in 1 ml culture medium 
containing 100 Hg/ml of 59Fe-loaded, ‘H-labelled transferrin 
(spec. act. as in tIg.1). (A) (0) 59Fe uptake by the cells; (B) 
(0) [ 3H] transferrin uptake by the cells. Mean results f SD of 
3 independent experiments are given. 
3.3. Short term kinetic experiments 
To further investigate the mechanism of transferrin 
uptake, short term kinetic experiments were carried 
out. As shown in figAA, up to 2 min continuous 
incubation at 37”C, erythroblasts accumulate 59Fe 
and 3H in comparable amounts; after 5 mm incuba- 
tion, whereas the uptake of “Fe continues to increase, 
that of 3H-label levels off and after 20 min incuba- 
tion, the cells have accumulated 2.5times more 59Fe 
121 
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Fig.4. Erythroblasts (-300 pg protein) were incubated from 
O-20 min at 37°C in 1 ml culture medium containing 
10 pg/ml of 59Fe-loaded, 3H-labelled transferrin (spec. act. as 
in fig.1) in the absence (A) or in the presence of 30 mM 
methylamine (B) or 1 mM chloroquine (C). Mean results 
f SD of 3 independent experiments are given: (0) 59 Fe uptake 
by the cells; (0) [ 3H] transferrin uptake by the cells. 
than 3H. We have also investigated the effect of 
chloroquine and methylamine on the uptake of 59Fe 
and ‘H during short term experiments (fig.4B,4C). In 
the presence of 10 mM methylamine, 59Fe and 3H are 
equally accumulated by the erythroblasts and in 
amounts comparable to the level reached by the 
3H-label in the absence of the drug; in the presence of 
100 /.IM chloroquine, the accumulation of both iso- 
topes is still comparable but further decreased by 
-50%. On the other hand at O’C, it should be noted 
that neither of these 2 drugs significantly affects the 
low temperature binding of transferrin to the cells 
(not shown). 
4. Discussion 
These data suggest hat rat erythroblasts take up 
iron from transferrin through the presence of recep- 
tors specific for the protein and located at the plasma 
membrane. The number of receptors (-500 OOO/cell) 
is high but can be compared to data for reticulocytes 
[ 171 which indicate the presence of 300 000 recep- 
tors/cell; the K, of the high affinity binding sites for 
transferrin is very close to published values (review 
[18]). At 37”C, these cells take up iron from trans- 
ferrin in a continuous process saturable with the 
transferrin concentration. However, considering the 
amount of 3H-label accumulated by the cells, and the 
absence of degradation of the protein, one has to con- 
clude that, as for cultured fibroblasts [4], there is a 
mechanism whereby after transferrin binding and iron 
release, the iron-depleted transferrin is returned in an 
intact form to the extra-cellular medium. From the 
short-term kinetics, one can estimate that the interac- 
tion of transferrin with the erythroblasts takes place 
within -5 min. At the saturating concentration of 
100 I.cg/ml and during 6 h incubation, erythroblasts 
corresponding to 1 mg cell protein have taken up 
7.4 ng 59Fe which corresponds to the amount of iron 
bound to 5 pg transferrin . h-’ . mg cell protein-‘. 
Assuming the presence of 500 000 receptors/cell and 
6 X IO6 erythroblasts/mg cell protein, each receptor 
must handle 12.5 transferrin molecules/h, i.e., 1 mol- 
ecule every 5 min. This fits very well with the estima- 
tion made from the short-term kinetics. 
The exact mechanism whereby transferrin iron is 
taken up by the erythroblasts is not known. As a first 
hypothesis, one can envisage that after binding of 
transferrin to its plasma membrane receptor, iron 
could be released, cross the membrane, and be incor- 
porated into the cytosol. A second mechanism is sim- 
ilar to what we have proposed to explain the iron 
uptake in fibroblasts, and furthermore, it takes into 
account the morphological experiments [2,3], which 
indicated that in erythroid cells, transferrin is endo- 
cytosed within intracellular vesicles. It consists in 
receptor-mediated endocytosis of transferrin, release 
of iron after fusion of the endocytic vesicle with a 
lysosome, and recycling of the iron-depleted trans- 
ferrin to the extracellular medium. The kinetic 
parameters are compatible with endocytosis and the 
effect of lysosomotropic agents provides strong argu- 
ments in favour of this mechanism. 
Considering that receptor-mediated endocytosis of 
transferrin, release of iron within an intracellular acidic 
granule and recycling of the iron-depleted transferrin 
are probably involved in iron uptake by different cell 
types, this mechanism could be general. However, the 
122 
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precise intracellular site where iron could be released 
from transferrin is not unequivocally established. 
There is considerable evidence in favour of lysosomes. 
The short term kinetics and the effect of lysosomo- 
tropic agents are compatible with the intralysosomal 
release of iron, and experimental evidence has been 
provided [ 19,201, showing that ligands tightly bound 
to the plasma membrane gain access to the lysosomes 
before being recycled back to the cell surface. How- 
ever, at this stage one cannot rule out that most of 
the iron could be released from transferrin in another 
intracellular acidic granule and therefore bypass the 
lysosomes and their hydrolytic enzymes. 
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